BA

Bhumika Ashishbhai Chovatiya

Active Director Additional Director DIN 10973265
DIN 10973265 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value •••• Premium profile

About Bhumika Ashishbhai Chovatiya

Data last updated:

Bhumika Ashishbhai Chovatiya is an Additional Director at Apindex Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Apindex Pharmaceuticals Private Limited reported revenue of ₹59.5 Lakh (FY 2025).

DIN 10973265
Primary Designation Additional Director
Industry Pharma
First Appointment 27 Feb 2025
Oldest Company Age 5 yrs
Largest company Apindex Pharmaceuticals Private Limited · ₹59.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director27 Feb 20252021₹59.5 Lakh (FY 2025)Active

Board colleagues of Bhumika Ashishbhai Chovatiya

Directorship timeline

Open interactive timeline →
Apindex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhumika Ashishbhai Chovatiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhumika Ashishbhai Chovatiya

Bhumika Ashishbhai Chovatiya currently holds 1 directorship: Apindex Pharmaceuticals Private Limited (Additional Director, since 27 Feb 2025, revenue ₹59.5 Lakh (FY 2025)).

Bhumika Ashishbhai Chovatiya was first appointed on 27 Feb 2025 as Additional Director at Apindex Pharmaceuticals Private Limited.

The current boards of Bhumika Ashishbhai Chovatiya's companies include Ashish Bharatbhai Chovatiya (Apindex Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available